Pharmacological Management of Brain Tumors
dc.contributor.advisor | Pórszász, Róbert | |
dc.contributor.advisordept | Department of Pharmacology and Pharmacotherapy | hu_HU |
dc.contributor.author | Okogwu, Louisa Chinwe | |
dc.contributor.department | DE--Általános Orvostudományi Kar | hu_HU |
dc.contributor.opponent | Szentmiklósi, József András | |
dc.contributor.opponent | Drimba, László | |
dc.contributor.opponentdept | Debreceni Egyetem::Általános Orvostudományi Kar::Farmakológiai és Farmakoterápiai Intézet | hu_HU |
dc.contributor.opponentdept | Kenézy Kórház, Központi Aneszteziológiai és Intezív Terápiás Osztály | hu_HU |
dc.date.accessioned | 2021-05-16T07:17:47Z | |
dc.date.available | 2021-05-16T07:17:47Z | |
dc.date.created | 2020-11-05 | |
dc.description.abstract | After decades of studies, brain tumors are one of the highest of all types of cancer. They can withstand almost all conventional and novel treatments is partly due to the unique cell-intrinsic and microenvironmental properties of neural tissues. So far, Glioblastoma multiforme is the most malignant form of brain tumors in adults. Gene therapy has been used in GBM with promising effects. | hu_HU |
dc.description.course | általános orvos | hu_HU |
dc.description.courselang | angol | hu_HU |
dc.description.coursespec | Orvosbiológia-farmakológia | hu_HU |
dc.description.degree | egységes, osztatlan | hu_HU |
dc.format.extent | 35 | hu_HU |
dc.identifier.uri | http://hdl.handle.net/2437/309666 | |
dc.language.iso | en | hu_HU |
dc.subject | brain tumors | hu_HU |
dc.subject | therapy | |
dc.subject | glioblastoma | |
dc.subject | chemotherapy | |
dc.subject | gene therapy | |
dc.subject.dspace | DEENK Témalista::Orvostudomány | hu_HU |
dc.title | Pharmacological Management of Brain Tumors | hu_HU |